Aristippos Gennadios, Group President Pharma & Consumer at Catalent, Inc. (CTLT), sold 2,338 shares at $59.55 ($139K) on 2024-08-02, disclosed to the SEC on 2024-08-05.
Seasonal sale ($139k) by Group President Pharma & Consumer — this insider has traded CTLT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.55 | 1,169 | $70K | 50.0% |
| 2 | $59.55 | 1,169 | $70K | 50.0% |
| Total | $59.55 avg | 2,338 | $139K | 100% |
| Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |
| CTLT | SELL | 2022-07-28 | $43K | — | Filing → |